Elevation of QT dispersion after obesity drug sibutramine

Journal of Cardiovascular Medicine

Volumn 11, Issue 11, 2010, Pages 832-835

  Yalcin, Ahmet A ^a   Yavuz, Bunyamin ^a   Ertugrul, Derun T ^a   Algul, Beyza ^a   Yilmaz, Hamiyet ^b   Deveci, Onur S ^a   Kucukazman, Metin ^a   Ata, Naim ^a   Demirel, Gokhan ^c   Dal, Kursat ^a   Tutal, Emre ^a  

^a Kecioren Teaching and Research Hospital ^*  (Turkey)

^b Aydn State Hospital   (Turkey)

^c Iskenderun Military Hospital   (Turkey)

Author keywords

arrhythmia; obesity; QT dispersion; sibutramine

Indexed keywords

ALANINE AMINOTRANSFERASE; ANGIOTENSIN RECEPTOR ANTAGONIST; ASPARTATE AMINOTRANSFERASE; CALCIUM CHANNEL BLOCKING AGENT; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIBUTRAMINE; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOCHEMISTRY; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; DIET RESTRICTION; DRUG EFFECT; ELECTROCARDIOGRAM; FEMALE; GLUCOSE BLOOD LEVEL; HEART ARRHYTHMIA; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; OBESITY; QT DISPERSION; QT PROLONGATION; SIDE EFFECT; TREATMENT DURATION; TREATMENT WITHDRAWAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTI-OBESITY AGENTS; ARRHYTHMIAS, CARDIAC; CALORIC RESTRICTION; COMBINED MODALITY THERAPY; CYCLOBUTANES; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; MIDDLE AGED; OBESITY; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TURKEY;

EID: 77958167691     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32833cdcbe     Document Type: Article

References (16)

1. Kautzner J, Malik M. QT interval dispersion and its clinical utility. PACE 1997; 20:2625-2640. (Pubitemid 27456334)
2. Zabel M, Portnoy S, Franz MR. Electrocardiographic indexes of dispersion of ventricular repolarization: an isolated heart validation study. J Am Coll Cardiol 1995; 25:746-752.
3. McNeely W, Goa KL. Sibutramine: a review of its contribution to the management of obesity. Drugs 1998; 56:1093-1124. (Pubitemid 29010230)
4. Lean ME. How does sibutramine work? Int J Obes Relat Metab Disord 2001; 25:S8-S11.
5. Arterburn DE, Crane PK, Veenstra DL. The efficacy and safety of sibutramine for weight loss: a systematic review. Arch Intern Med 2004; 164:994-1003. (Pubitemid 38581520)
6. Deitel M. Sibutramine warning: hypertension and cardiac arrhythmias reported (editorial). Obes Surg 2002; 2:422. (Pubitemid 34621046)
7. Harrison-Woolrych M, Clark DW, Hill GR, Rees MI, Skinner JR. QT interval prolongation associated with sibutramine treatment. Br J Clin Pharmacol 2006; 61:464-469.
8. Yavuz B, DeveciOS, Yavuz BB, Halil M, Aytemir K, Cankurtaran M, et al. QT dispersion increases with aging. Ann Noninvasive Electrocardiol 2006; 11:127-131.
9. Marek M, Camm AJ. Mystery of QTc interval dispersion. Am J Cardiol 1997; 79:785-787.
10. Zabel M, Woosly RL, Franz MR. Is dispersion of ventricular repolarisation rate dependent? PACE 1997; 20:2405-2411. (Pubitemid 27456350)
11. Torp-Pedersen C, Caterson I, Coutinho W, Finer N, Van Gaal L, Maggioni A, et al., SCOUT Investigators. Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial. Eur Heart J 2007; 28:2915-2923. (Pubitemid 350233016)
12. Philip W, James T. The SCOUT study: risk-benefit profile of sibutramine in overweight high risk cardiovascular patients. Eur Heart J 2005; 7 (Suppl L): L44-L48.
13. Ernest D, Gershenzon A, Corallo CA, Nagappan N. Sibutramineassociated QT interval prolongation and cardiac arrest. Ann Pharmacother 2008; 42:1514-1517.
14. Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the Ikr potassium channel. Cell 1995; 81:299-307.
15. Kim KS, Kim EJ, Lee HA, Park SJ. Effect of sibutramine HCl on cardiac hERG K+ channel. Mol Cell Biochem 2009; 320:125-131.
16. Hu S, Wang S, Gibson J, Gilbertson TA. Inhibition of delayed rectifier K channels by dexfenfluramine (Redux). J Pharmacol ExpTher 1998; 287:480-486. (Pubitemid 29133643)